Advanced Enzyme Technologies Reports 20% Revenue Growth in Q1 FY26 Aug 02, 2025
JC Biotech, Subsidiary of Advanced Enzyme Tech, Approves Solar Power Investment Partnership with Raywatt Solar Jul 25, 2025
Advanced Enzyme Technologies Expands into Nutrition and Wellness with New Subsidiary Jul 04, 2025
Advanced Enzyme Tech Reports Mixed Q4 Results with Revenue Growth and Profit Dip May 13, 2025
More news about Advanced Enzyme Tech
13Mar 25
Advanced Enzyme Technologies Gears Up for Analyst and Investor Meeting
Advanced Enzyme Technologies Ltd (AETL) has announced a virtual one-on-one meeting with Raintree Family Office on March 19, 2025. The meeting, disclosed in compliance with SEBI regulations, aims to provide updates on company performance and discuss future strategies. While the specific agenda is not revealed, such meetings typically cover recent financial results, market trends, and company outlook. The announcement has sparked interest among investors and market watchers, potentially impacting short-term stock performance. AETL's Company Secretary emphasized their commitment to stakeholder transparency by uploading the meeting information on the company website.